Medtronic stock: BTIG cuts target for Medtronic stock to USD 99.00 from USD 100.00

Published on 10/19/2026 at 16:54 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

First-quarter revenue rose 13.70 percent to USD 9.76 billion. Medtronic stock costs EUR 83.03 on October 19, 2026, 1.60 percent below Xetra close.

Target and operating growth

BTIG lowered its Medtronic target to USD 99.00 from USD 100.00 on October 12, 2026.
Fiscal first-quarter revenue rose 13.70 percent to USD 9.76 billion through July 31, 2026.
Medtronic stock costs EUR 83.03 at Lang & Schwarz on October 19, 2026 at 4:42 p.m. CEST, 1.60 percent below the Xetra close of October 16, 2026 at EUR 84.38.
Medtronic is scheduled to report its next results on November 17, 2026.

Architekturrender eines modernen Glas-Bürogebäudes mit Teich und Landschaftsgestaltung — Medtronic plc (ISIN IE00BTN1Y115) Architektur-Render eines modernen Glas-Hauptsitzes mit Teich und Grünanlage, Illustration mit AI erstellt.

BTIG lowered its Medtronic target from USD 100.00 to USD 99.00 on October 12, 2026, according to Markets Insider. The revised target stood 6.45 percent above the USD 93.00 NYSE price at 10:53 a.m. ET on October 19, 2026. At Lang & Schwarz, Medtronic stock was trading at EUR 83.03 on October 19, 2026 at 4:42 p.m. CEST, down 1.60 percent versus the Xetra close of October 16, 2026 at EUR 84.38.

Revenue reached USD 9.76 billion

Medtronic's fiscal first-quarter revenue rose 13.70 percent year over year to USD 9.76 billion for the period ended July 31, 2026. Diluted GAAP earnings per share reached USD 1.14, up from USD 0.81 in the year-ago quarter, while net income attributable to Medtronic rose 41.40 percent to USD 1.47 billion, according to Financial Report Insights.

Price position and trading range

The USD 73.31 to USD 106.33 52-week range places the NYSE price of USD 93.00 12.55 percent below the high and 26.80 percent above the low. Medtronic's current euro quote is below the October 16 Xetra close, while the US listing was down 1.85 percent at the cited October 19 time. The Lang & Schwarz bid was EUR 82.94 and the ask was EUR 83.12.

Valuation and next results

Medtronic's market capitalization was USD 118.9 billion on October 19, 2026, with a price-to-earnings ratio of 22.93 and a dividend yield of 3.00 percent. The company is scheduled to report its next results on November 17, 2026, according to Kaplio.

Comparison with peers

Medtronic plc: minus 1.60 percent, P/E 22.93, market capitalization USD 118.9 billion

Abbott Laboratories (NYSE, USD): minus 1.12 percent, P/E 33.34, market capitalization USD 179.5 billion

Stryker Corporation (NYSE, USD): plus 0.62 percent, P/E 30.73, market capitalization USD 113.7 billion

Price and investor perspective

The analyst target revision gives the stock a defined valuation reference, while the first-quarter revenue increase shows that growth remained visible in the latest reported period. The next results date will provide the next scheduled test of that trend.

Medtronic stock was trading at EUR 83.03 at Lang & Schwarz on October 19, 2026 at 4:42 p.m. CEST, 1.60 percent below the Xetra close of October 16, 2026 at EUR 84.38. The further course of trading is shown by the continuously updated real-time quote of Medtronic stock.